FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012040575> ?p ?o ?g. }

• W2012040575 endingPage "215" @default.
• W2012040575 startingPage "207" @default.
• W2012040575 abstract "It is well established that α-adrenoceptor agonists have sedative and antinociceptive properties. In the current behavioral study we tried to find out if the α-adrenergic sedative and antinociceptive effects can be dissociated. We tested the hypothesis that α adrenergic sedation is mediated by the locus coeruleus (LC) and antinociception by spinal α-adrenoceptors. Also, we addressed the possibility that intracerebral injection of an α-agonist might produce its antinociceptive effect by an action directly at the spinal cord. Medetomidine, an α-adrenergic agonist, or atipamezole, an α-adrenergic antagonist, were microinjected bilaterally into the LC through chronic cannulae in unanesthetized Han-Wistar rats. The effect on locomotor activity (/vigilancc). tail-flick and hot-plate response, and on formalin-induced pain behavior was determined. Medetomidine microinjected into the LC (1–10 μg/cannula) produced dose-dependently hypolocomotion (/sedation), increase of response latencies in the hot-plate and the tail-flick tests, and a decrease in the formalin-induced pain behavior. Hypolocomotion (/sedation) was obtained at a lower medetomidine dose (1 μg/cannula) than antinociception (3–10 μg/cannula). The lowest medetomidine dose used (1 μg/cannula), which induced significant hypolocomotion (/sedation), produced either no antinociception (hot-plate and tail-flick tests) or even a slight hyperalgesia (formalin test). The hypolocomotion (/sedation) but not antinociception (tail-flick test) induced by systemic administration of medetomidine (100 μg/kg s.c.) could be reversed by atipamezole (10 μg/cannula) microinjected into the LC. Only a high systemic dose of atipamezole (1 mg/kg s.c.) reversed the antinociceptive effects of medetomidine. Microinjection of medetomidine into the LC (3 μg/cannula) produced antinociception (tail-flick test) also in spinal rats. which effect was completely reversed by atipamezole (l mg/kg s.c.). Following administration of medetomidine at the dose of 1 μg/cannula into the central or cortical nucleus of the amygdala (control sites) there was no significant effect on locomotor activity, hot-plate response, or formalin-induced pain. The results indicate that α-adrenergic sedative and pain-modulating effects can be dissociated following microinjection of medetomidine into the LC. The antinociceptive effect of the supraspinally microinjected medetomidine in Han-Wistar rats could be explained by direct activation of the spinal α-adrenoceptors, whereas the sedation/hypolocomotion could he explained by an action on the α-adrenoceptors located in the LC, or its immediate vicinity." @default.
• W2012040575 created "2016-06-24" @default.
• W2012040575 creator A5001477253 @default.
• W2012040575 creator A5005184266 @default.
• W2012040575 creator A5072325359 @default.
• W2012040575 creator A5079810035 @default.
• W2012040575 creator A5083713986 @default.
• W2012040575 date "1994-05-01" @default.
• W2012040575 modified "2023-10-14" @default.
• W2012040575 title "Dissociation of the α 2-adrenergic antinociception from sedation following microinjection of medetomidine into the locus coeruleus in rats" @default.
• W2012040575 cites W1026910736 @default.
• W2012040575 cites W1965443085 @default.
• W2012040575 cites W1965862001 @default.
• W2012040575 cites W1972211185 @default.
• W2012040575 cites W1976288735 @default.
• W2012040575 cites W1976994098 @default.
• W2012040575 cites W1982324672 @default.
• W2012040575 cites W1985525186 @default.
• W2012040575 cites W1990988036 @default.
• W2012040575 cites W1997386700 @default.
• W2012040575 cites W1997662455 @default.
• W2012040575 cites W1999755237 @default.
• W2012040575 cites W2000695181 @default.
• W2012040575 cites W2001933690 @default.
• W2012040575 cites W2014321807 @default.
• W2012040575 cites W2015759203 @default.
• W2012040575 cites W2015876007 @default.
• W2012040575 cites W2018864594 @default.
• W2012040575 cites W2019237255 @default.
• W2012040575 cites W2022012727 @default.
• W2012040575 cites W2024136403 @default.
• W2012040575 cites W2025142129 @default.
• W2012040575 cites W2052738055 @default.
• W2012040575 cites W2059625918 @default.
• W2012040575 cites W2060910799 @default.
• W2012040575 cites W2068256898 @default.
• W2012040575 cites W2072709003 @default.
• W2012040575 cites W2077492163 @default.
• W2012040575 cites W2080331799 @default.
• W2012040575 cites W2086476276 @default.
• W2012040575 cites W2088640860 @default.
• W2012040575 cites W2093214674 @default.
• W2012040575 cites W2164153190 @default.
• W2012040575 cites W47887686 @default.
• W2012040575 doi "https://doi.org/10.1016/0304-3959(94)90225-9" @default.
• W2012040575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7916451" @default.
• W2012040575 hasPublicationYear "1994" @default.
• W2012040575 type Work @default.
• W2012040575 sameAs 2012040575 @default.
• W2012040575 citedByCount "53" @default.
• W2012040575 countsByYear W20120405752012 @default.
• W2012040575 countsByYear W20120405752013 @default.
• W2012040575 countsByYear W20120405752014 @default.
• W2012040575 countsByYear W20120405752015 @default.
• W2012040575 countsByYear W20120405752016 @default.
• W2012040575 countsByYear W20120405752017 @default.
• W2012040575 countsByYear W20120405752018 @default.
• W2012040575 countsByYear W20120405752020 @default.
• W2012040575 countsByYear W20120405752021 @default.
• W2012040575 countsByYear W20120405752022 @default.
• W2012040575 crossrefType "journal-article" @default.
• W2012040575 hasAuthorship W2012040575A5001477253 @default.
• W2012040575 hasAuthorship W2012040575A5005184266 @default.
• W2012040575 hasAuthorship W2012040575A5072325359 @default.
• W2012040575 hasAuthorship W2012040575A5079810035 @default.
• W2012040575 hasAuthorship W2012040575A5083713986 @default.
• W2012040575 hasConcept C126322002 @default.
• W2012040575 hasConcept C134018914 @default.
• W2012040575 hasConcept C141071460 @default.
• W2012040575 hasConcept C15490471 @default.
• W2012040575 hasConcept C170493617 @default.
• W2012040575 hasConcept C185592680 @default.
• W2012040575 hasConcept C2776312488 @default.
• W2012040575 hasConcept C2776814716 @default.
• W2012040575 hasConcept C2777602617 @default.
• W2012040575 hasConcept C2777953023 @default.
• W2012040575 hasConcept C2778074680 @default.
• W2012040575 hasConcept C2778468602 @default.
• W2012040575 hasConcept C2778938600 @default.
• W2012040575 hasConcept C2779520467 @default.
• W2012040575 hasConcept C42219234 @default.
• W2012040575 hasConcept C529278444 @default.
• W2012040575 hasConcept C62525196 @default.
• W2012040575 hasConcept C71924100 @default.
• W2012040575 hasConcept C84393581 @default.
• W2012040575 hasConcept C98274493 @default.
• W2012040575 hasConceptScore W2012040575C126322002 @default.
• W2012040575 hasConceptScore W2012040575C134018914 @default.
• W2012040575 hasConceptScore W2012040575C141071460 @default.
• W2012040575 hasConceptScore W2012040575C15490471 @default.
• W2012040575 hasConceptScore W2012040575C170493617 @default.
• W2012040575 hasConceptScore W2012040575C185592680 @default.
• W2012040575 hasConceptScore W2012040575C2776312488 @default.
• W2012040575 hasConceptScore W2012040575C2776814716 @default.
• W2012040575 hasConceptScore W2012040575C2777602617 @default.
• W2012040575 hasConceptScore W2012040575C2777953023 @default.
• W2012040575 hasConceptScore W2012040575C2778074680 @default.
• W2012040575 hasConceptScore W2012040575C2778468602 @default.

• next